In this project, a product platform is developed which enables the most important in vitro diagnostic tests for immediate point-of-care use.
Intelligent linking of molecular biological and Raman spectroscopic approaches to non-invasive, rapid and reliable diagnosis of pneumonia.
Technology concept for universal use in the laboratory as well as for mobile analytics.
Modeling and research into a modular system for error-free use of microfluidics in point-of-care devices (μToolbox).
Development of a test system for the differentiation of colonising and infecting Staphylococcus aureus strains.
Detection of pathogen components from urine for the monitoring of patients at risk and for early diagnosis and therapy.
Identifying and validating markers and establishing equipment-based solutions for pneumonia diagnosis in immunosuppressed patients.
Design, verification and validation of different microarray-based assays for genotypic and phenotypic specific and sensitive detection of different carbapenemases.
Development of a rapid test for the detection of multi-resistant gram-negative bacteria - so-called extended spectrum beta-lactamase formers.
Development of a biobank for the InfectoGnostics patient cohorts.
1 from 2